Emergency Use Listing by WHO

  • September 15, 2021
  • Posted by: OptimizeIAS Team
  • Category: DPN Topics
No Comments

 

 

Emergency Use Listing by WHO

Subject – Science and Tech

Context – Covaxin may get WHO approval soon

Concept –

  • The WHO EUL is a risk based procedure for assessing and listing unlicensed vaccines, therapeutics and in-vitro diagnostics with the ultimate aim of expediting the availability of these products to people affected by a public health emergency.
  • Emergency Use Listing (EUL) is the procedure to streamline the process by which new or unlicensed products can be used during public health emergencies.
  • The EUL replaces the Emergency Use Assessment and Listing (EUAL) procedure, which was used during the West Africa Ebola outbreak of 2014-2016.
  • The WHO established its emergency use listing (EUL) process to help poorer countries without their own regulatory resources quickly approve medicines new diseases like Covid-19, which otherwise could lead to delays.
  • The EUL is not intended to interfere with ongoing clinical trials.
  • The process may include on-site inspections of the company’s facilities.

Emergency Use Listing by WHO Science and tech